• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

NJ ACTS Special Populations Core 2021 Webinar Series – October 12th

by William Jester | Oct 11, 2021 | News

Featuring the Research of Dr. Soko Setoguchi, Dr. Bonnie Qin and Dr. Jennifer Miles Tuesday, October 12: 12:00pm – 1:00pm Environmental and Community Determinants of Health: Exploring Health Outcomes Using Area-Level Data – Health outcomes are increasingly...

COVID-19 booster shots: former acting HHS secretary weighs in after FDA advisory board endorsement

by William Jester | Oct 10, 2021 | Community, Covid, News

Former Health and Human Services (HHS) Acting Secretary and Deputy Secretary Eric Hargan, who served under both the Bush and Trump administrations, says the Food and Drug Administration (FDA) has been rightfully cautious about approving COVID-19 vaccine booster...

The 6 Different Types of Pneumonia, Explained by Doctors.

by William Jester | Oct 8, 2021 | Community, Covid, News

It’s easy to assume all cases of pneumonia are created equal, but there are actually several different types of the infection—and knowing the kind of pneumonia that you have can be crucial in order to get you the proper care you need. “The different types...

Booster vs. third dose: What’s the difference, and which do you need?

by William Jester | Oct 7, 2021 | Community, Covid, News

Between the rise of the delta coronavirus variant, fear of waning immunity due to breakthrough COVID-19 cases and the White House announcement that all adults will need a COVID-19 booster starting as early as Sept. 20, news has been flooded with unsatisfying advice...

NJIT’s Xu is Developing a Timed-Release mRNA Vaccine with an Extended Shelf Life

by William Jester | Oct 6, 2021 | Community, News

Xiaoyang Xu, a chemical and materials engineer at NJIT who specializes in nanomedicines, has secured a $1 million award from the Gustavus and Louise Pfeiffer Research Foundation to develop the next generation of messenger RNA (mRNA) vaccines. Xu’s immediate goal is to...
« Older Entries
Next Entries »

Recent Posts

  • Join NJ ACTS Special Populations for a Seminar on 10/27
  • Join NCATS on 10/9 for the Director’s Roundtable
  • Mentoring Biomedical Graduate Students and Postdocs – Workshop 10/9
  • NJ ACS Community Event on 10/13 from 10:30 – 12:00
  • NJ ACTS Special Populations Seminar 9/29 – Register Now

Archives

  • 2026
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,502)
  • Covid (1,001)
  • CTO Events (6)
  • News (3,179)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.